About MULTIMERIC BIOTHERAPEUTICS INC
Multimeric Biotherapeutics, Inc. is developing the FortiVac™ vaccine platform to address unmet medical needs in cancer treatment and prevention of serious infections by activating strong CD8+ T cell responses.
Development of FortiVac™ vaccine platformActivation of CD8+ T cell responses using CD40L and antigen fusion proteinsPatented fusion protein technology using surfactant protein D (SPD) multimerization scaffold
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MULTIMERIC BIOTHERAPEUTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.